|
3M submitted a supplemental report to the EPA detailing a pharmacokinetic study that found perfluorooctanesulfonyl fluoride (POSF) metabolizes to perfluorooctane sulfonate (PFOS) in rats, with peak PFOS concentrations observed in the liver on day 4 post-dose.
|
2004 |
AR226-1694
|
0LgKpvk3o48ZxonVeo3LqREXb |
1 |
|
3M submitted a supplemental report to the EPA detailing a pharmacokinetic study that found perfluorooctanesulfonyl fluoride (POSF) metabolizes to perfluorooctane sulfonate (PFOS) in rats, with maximum PFOS concentration observed in the liver on day 4 post-dose.
|
2004 |
AR226-1694
|
ByVvDBNOBXmJQV9VGEM431D94 |
1 |